P2 Capital Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-200,000
Closed -$3.34M 15
2024
Q3
$3.34M Hold
200,000
0.38% 15
2024
Q2
$2.37M Sell
200,000
-2,750,000
-93% -$31.4M 0.26% 18
2024
Q1
$35.4M Buy
2,950,000
+600,000
+26% +$8.93M 4.19% 11
2023
Q4
$39.6M Buy
2,350,000
+500,000
+27% +$7.08M 4.36% 11
2023
Q3
$27.7M Buy
1,850,000
+700,000
+61% +$11.8M 3.63% 12
2023
Q2
$21.7M Buy
+1,150,000
New +$18.3M 2.52% 13

Other funds holding SHC

P2 Capital Partners's SHC Position: Q4 2024 in Review

P2 Capital Partners sold out of Sotera Health (SHC) in Q4 2024, closing a stake of 200,000 shares — an estimated $3.34M sold.

P2 Capital Partners first reported a position in SHC in Q2 2023 and held it in 6 quarters. The position peaked at $39.6M in Q4 2023. 216 funds tracked by Wall St. Rank hold SHC as of Q4 2024.

  • P2 Capital Partners reported no remaining Sotera Health position as of Q4 2024 after selling out during the quarter.
  • P2 Capital Partners sold 200,000 Sotera Health shares in Q4 2024, an estimated $3.34M.
  • P2 Capital Partners first reported a position in Sotera Health in Q2 2023 and held it in 6 quarters.
  • P2 Capital Partners's Sotera Health position peaked at $39.6M in Q4 2023.
  • 216 funds tracked by Wall St. Rank held Sotera Health as of Q4 2024.

Based on P2 Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.